Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Clover Health Investments, Corp. (CLOV) had Revenue of $749.19M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$749.19M
Net Income	$27.33M
Cost of Goods Sold	$589.65M
Gross Profit	$159.54M
Operating Expenses	$721.86M
Operating Income	$27.33M
Non-Operating Income/Expense	--
Pre-Tax Income	$27.33M
Normalized Pre-Tax Income	$27.33M
Income after Taxes	$27.33M
Income from Continuous Operations	$27.33M
Consolidated Net Income/Loss	$27.33M
Normalized Income after Taxes	$27.33M
EBIT	$27.33M
EBITDA	$27.41M
Weighted-Average Shares Outstanding (Basic)	522.18M
Weighted-Average Shares Outstanding (Diluted)	532.50M
Earnings per Share (EPS) (Basic)	$0.05
Earnings per Share (EPS) (Diluted)	$0.05
Balance Sheet Financials
Current Assets	$448.02M
Property, Plant, and Equipment	$6.90M
Long-Term Assets	$249.71M
Total Assets	$697.73M
Current Liabilities	$336.58M
Long-Term Debt	--
Long-Term Liabilities	$21.72M
Total Liabilities	$358.30M
Common Equity	$339.43M
Tangible Shareholders Equity	$336.44M
Shareholders Equity	$339.43M
Common Shares Outstanding	525.27M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$107.89M
Cash Flow from Investing Activities	$-5.07M
Cash Flow from Financial Activities	$-7.86M
Beginning Cash	$78.30M
End Cash	$173.26M
Increase/Decrease in Cash	$94.96M
Stock-Based Compensation	$12.27M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.33
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	21.30%
Operating Margin	3.65%
EBIT Margin	3.65%
EBITDA Margin	--
Pre-Tax Profit Margin	3.65%
Profit Margin	3.65%
Free Cash Flow	$107.04M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.07
Inventory Turnover	--
Receiveable Turnover	10.20
Days Sales in Receivables	8.83
Return on Equity	8.05%
Return on Tangible Equity	8.12%
Return on Assets	3.92%
Return on Investments	8.05%
Book Value Per Share	$0.65
Free Cash Flow per Share	$0.20
Operating Cash Flow per Share	$0.20

Data from Zacks Investment Research, Inc.